... ed to the bio-data page, of which the main theme is the Golden Bauhinia Square. Full-color ultraviolet printing technology will be also adopted for visa pages, on which a night view of the northern pa ...More
EJ Insight2019-05-10
... uring and bio-pharmaceutical sectors, according to the statement from the China Securities Regulatory Commission (CSRC). The regulator stressed that the new tech board is part of China’s tech-driven d ...More
EJ Insight2019-04-16
... atics and bio-chemistry at the MIT and earned a master degree in public health from the University of California at Los Angeles. She returned permanently to Thailand in 2001, performing royal duties b ...More
EJ Insight2019-02-08
... set up a bio-analytical laboratory in San Diego, California. It also intends to fund the acquisition of contract research organization companies. WuXi shares will begin trading in Hong Kong on Dec. 1 ...More
EJ Insight2018-12-07
... hangsheng Bio-technology (002680.CN), the company at the center of a nationwide vaccine safety scandal that faces the risk of delisting. A “special treatment” stock, Changsheng rose the maximum 5 perc ...More
EJ Insight2018-11-16
... the Earth BioGenome Project (EBP) as “the next moonshot for biology” after the Human Genome Project, a 13-year, US$3 billion endeavor to map human DNA which was completed in 2003. The EBP is expected ...More
EJ Insight2018-11-02
... Cambridge Bio-Augmentation Systems (CBAS) is working on a "prosthetic interface device" (PID), a neural interface that is integrated into the bone, the skin and the nervous system. Out from the end of ...More
EJ Insight2018-11-01
... tors were biotechnology, up 15.4 percent, petrochemicals with 13.8 percent growth, and electronics and IT, up 11.6 percent. Output of high-tech companies rose 15.9 percent. Actual foreign investment i ...More
EJ Insight2018-09-03
... hangsheng Bio-technology Co. Ltd. of selling 252,600 doses of ineffective DPT vaccines to inoculate children against diphtheria, whooping cough and tetanus, Reuters said. Xinhua said on Wednesday furt ...More
EJ Insight2018-08-16
In mid-July, China's state drug administration ordered Changsheng Bio-technology, a company headquartered in Changchun in northeastern China, to stop production of rabies vaccines after it uncovered e ...More
EJ Insight2018-08-16
... hangsheng Bio-technology, a company headquartered in Ch ...全文
今日信報時事評論EJ InsightFrank Ching2018年08月16日
